G(

GluBio (格博生物)

San Diego, United States · Founded 2021 · $102.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$102.0M
Last Round
$30.0M Corporate RoundFeb 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

GluBio Therapeutics Inc. ("GluBio") is a biotechnology company dedicated to the discovery and development of novel molecular glue degraders (MGDs), with a mission to address unmet clinical needs across oncology, autoimmune diseases, and genetic disorders, etc. Since its establishment in March 2021, the company has secured funding from top-tier investors, including Hillhouse Capital, Qiming Venture Partners, Lilly Asia Ventures, Kaitai Capital, Legend Capital, K2VC, E Fund Capital and Sanofi.

Summary

GluBio (格博生物) is a Biotech company based in San Diego, United States, founded in 2021. It has raised $102.0M in total across 3 rounds, most recently a $30.0M Corporate Round in Feb 2026. Investors include Sanofi Ventures, Qiming VP and Lilly Asia Ventures.

Funding History

Corporate RoundCorporate RoundFeb 2026
$30.0M

Sign up to see all 3 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GluBio (格博生物) on Indexed.vc
<a href="https://indexed.vc/companies/glubio"><img src="https://indexed.vc/api/badge/company/glubio" alt="GluBio (格博生物) on Indexed.vc" width="260" height="76" /></a>